S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CTMX CytomX Therapeutics Inc

0.80

0.0417 (5.50%)

Feb 12 2025 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more CytomX Therapeutics Charts.

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more CytomX Therapeutics Charts.

CytomX Therapeutics Inc News

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Monday 10 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 3 February 2025 (1 week ago) • Edgar (US Regulatory)

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Wednesday 8 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
Monday 6 January 2025 (1 month ago) • GlobeNewswire Inc.

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Wednesday 27 November 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Thursday 7 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

More CytomX Therapeutics Inc News Articles

International Endeavors (PK)

Anavex Life Sciences

Greater Cannabis (PK)

Adia Nutrition (PK)

Intergrated Cannabis Sol... (PK)

Green Leaf Innovations (PK)

Rennova Health (CE)

Enanta Pharmaceuticals

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions